ZANDR was established at the Children´s Cancer Research Institute (CCRI) in 2019 and is a unique platform to phenotypically screen small compounds on zebrafish models of human diseases.
Zebrafish and in particular zebrafish larvae is a well suited vertebrate model system to investigate various human diseases and to perform cost-effective screens for small molecules with therapeutic potential (1). Funded by FFG, we have established a zebrafish-optimized and automated screening platform, which is open to the scientific community. Please contact us, if you are interested in collaboration.
ZANDR Symposium 11th October 2019: Schedule ZANDR Symposium
1) MacRae CA & Peterson RT (2015), Zebrafish as tools for drug discovery, Nat Rev Drug Discov. Oct;14(10):721-31. Doi: 10.1038/nrd4627
The ZANDR platform (Danio4Can Project) received funding by the FFG´s 1st Infrastructure Funding Call (2016).